Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
16 studies found for:    Open Studies | "Hemochromatosis"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hemochromatosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Treatment of Hemochromatosis
Condition: Hemochromatosis
Intervention:
2 Unknown † Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
Condition: Hemochromatosis
Interventions: Procedure: Arm 1: Erythrocyte apheresis;   Procedure: Arm 2: Whole blood phlebotomy
3 Unknown † Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
Conditions: Hemochromatosis;   Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Other: Venesection
4 Recruiting Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
Condition: Hemochromatosis Type 1
Intervention: Procedure: First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)
5 Recruiting Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
Condition: Refractory Hemochromatosis Rheumatism
Intervention: Drug: Anakinra
6 Recruiting Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis
Conditions: Myocardial Iron Overload;   HFE-Associated Hereditary Hemochromatosis
Interventions: Device: 3Tesla cardiac MRI;   Device: Electrocardiogram (EKG);   Biological: Iron and cardiac markers;   Biological: Pregnancy test;   Device: Echocardiography at rest;   Biological: Urinary pregnancy test;   Device: 3Tesla abdominal MRI
7 Unknown † Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis
Condition: Hemochromatosis
Intervention: Drug: Pantoprazole
8 Unknown † Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis
Condition: Hereditary Haemochromatosis
Intervention: Other: Interviews, questionaires, RAND-modified delphi method round
9 Recruiting Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.
Conditions: Hemochromatosis, Type 4;   Ferroportin Disease;   Dysmetabolic Hepatosiderosis;   Diagnosis
Intervention: Drug: iron fumarate
10 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
11 Unknown † Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Conditions: Glomerulonephritis, Membranous;   Neonatal Diseases and Abnormalities;   Hemochromatosis
Intervention:
12 Recruiting Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?
Condition: Hereditary Haemochromatosis
Interventions: Procedure: Erythrocytapheresis;   Procedure: Plasmapheresis
13 Recruiting Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Conditions: Iron Overload;   Hemochromatosis;   Hemosiderosis
Intervention: Other: MRI
14 Unknown † Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Conditions: Anemia, Sickle Cell;   Transfusion Hemochromatosis
Intervention: Drug: deferasirox
15 Recruiting Liver Fibrosis in Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Other: Liver transient elastography (Fibroscan);   Other: Ferriscan;   Procedure: Liver biopsy in iron overloaded subjects.
16 Recruiting Massive Iron Deposit Assessment
Conditions: Iron Overload;   Excessive Body Iron Burden
Interventions: Device: R2*-UTE;   Device: R2*-GRE;   Procedure: Liver biopsy
To Top

† Indicates status has not been verified in more than two years